Global Leukapheresis Market: Trends and Forecast Size, Share, 2032

7 min read1 day ago

The global leukapheresis market was estimated to be worth USD 216.81 million in 2023 and is expected to grow to USD 437.02 million by the end of 2032, per a report released by Zion Market Research. Over the course of the projected period, the market is anticipated to expand at a CAGR of 8.1%. The study examines the factors driving, impeding, and influencing demand in the worldwide leukapheresis market over the course of the forecast period. Additionally, it will assist in navigating and investigating the emerging potential in the field of leukapheresis.

✈👉Get a Free Sample: 🚀https://www.zionmarketresearch.com/sample/leukapheresis-market

The leukapheresis market is integral to the treatment of various hematological disorders, particularly cancer-related blood diseases such as leukemia and lymphoma. Leukapheresis, a specialized blood filtration process, allows for the selective removal of specific blood components, such as leukocytes, from a patient’s blood. This process is widely used in both therapeutic and research settings, especially in immunotherapy treatments. This article explores the key trends, market drivers, challenges, and future outlook for the leukapheresis market.

Overview of the Global Leukapheresis Market

Leukapheresis is a laboratory technique used to extract white blood cells from a blood sample. It is a specialised type of apheresis, which is the more general word for removing one particular component of blood and reintroducing the rest into the bloodstream. Leukapheresis can be used to lower a very high white blood cell count and harvest autologous U.S. blood cells for study before reintroducing them into the patient’s body. To be exact, leukapheresis is a rare procedure used to donate blood.

The global leukapheresis market was valued at $2.3 billion in 2023 and is projected to grow at a CAGR of 7.2% from 2024 to 2030. This growth is largely driven by the increasing prevalence of blood cancers, the rising demand for targeted therapies, and technological advancements in leukapheresis equipment and techniques.

Growth Factors for the Global Leukapheresis Market

The market for leukapheresis is expected to grow in the upcoming years due to a number of factors, including rising leukaemia incidence and prevalence, growing demand for leukopaks for research applications, and an increase in blood donations. Researchers from all around the world are looking into new areas, such paediatrics, to apply leukapheresis, which will increase the market’s potential in the near future.

However, the high expense of leukopaks and therapeutic leukapheresis, as well as stringent government regulations controlling leukocyte donor selection, will have a negative effect on the market’s expansion in the years to come. Furthermore, complications surrounding therapeutic leukapheresis could further impede market growth during the next ten years. However, the widespread adoption of the process for isolating white blood cells for research purposes, such as the creation of cell-based immunotherapies, would open up a wide range of growth prospects for market participants in the leukapheresis industry.

Global Market Segmentation for Leukapheresis

Based on product, leukopaks, application, and end user, the worldwide leukapheresis market may be segmented. The market is divided into four segments based on the product: disposables, leukocyte filters, apheresis machines, and columns. The market for leukapheresis is divided into three segments based on leukopaks: human primary cells, mobilised cells, and non-mobilized cells. The market is divided into two segments based on application: research and therapeutic. The market is separated into research institutes and hospitals based on the final U.S. consumer.

✈👉Directly Purchase a copy of the report with TOC: 🚀https://www.zionmarketresearch.com/toc/leukapheresis-market

Market for Leukapheresis: Report Scope

Regional Analysis of the Global Leukapheresis Market

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the five major regions into which the worldwide leukapheresis market may be separated. Asia Pacific was predicted to hold the biggest market share for leukopaks and leukapheresis products in 2018, followed by North America and Europe. The region’s growing regenerative medicine research, the number of CAR-T therapy clinical trials, and the presence of top pharmaceutical and biotech companies concentrating on cell therapy research are all factors contributing to Asia Pacific’s notable growth in the leukapheresis market.

The market for leukapheresis is expected to grow in the upcoming years due to a combination of increased government and private funding for biotechnology research in North American nations like the United States and Canada, as well as an increase in ongoing pharmaceutical research and development activities. Furthermore, a large number of well-known pharmaceutical and biotech companies have their headquarters in the United States, which is projected to give the region’s leukapheresis market a significant boost. The market in the European region has enormous growth potential and is expected to rise at a remarkable rate over the next years.

Key Market Drivers

Rising Incidence of Hematological Cancers The increasing prevalence of leukemia, lymphoma, and other blood cancers is one of the major factors contributing to the growth of the leukapheresis market. Leukapheresis plays a crucial role in stem cell collection for bone marrow transplants and for the extraction of specific cells for cancer treatments.
Growth of Immunotherapy and Cell Therapies Leukapheresis is essential in the field of immunotherapy, particularly in the collection of T-cells and other immune cells for CAR-T (chimeric antigen receptor T-cell) therapy. As immunotherapy becomes more prevalent in cancer treatment, the demand for leukapheresis technologies continues to grow.
Technological Advancements in Leukapheresis Equipment Continuous improvements in apheresis technology, such as the development of automated systems, more precise blood component separation, and enhanced patient comfort, are contributing to the market’s growth. These advancements are also expanding the range of applications for leukapheresis, making it an essential tool in a variety of medical treatments.
Increased Awareness and Adoption of Leukapheresis As healthcare systems and professionals become more aware of the benefits of leukapheresis in cancer and autoimmune disease treatment, the adoption of these techniques has risen significantly. The increasing number of specialized centers and treatment facilities offering leukapheresis is driving the demand for related devices and services.

Market Segmentation

By Type of Leukapheresis
By Application
By End-User

Regional Insights

North America North America holds the largest market share for leukapheresis, driven by the presence of advanced healthcare facilities, high treatment adoption rates, and increasing cancer incidence. The U.S. dominates this region, where innovations in immunotherapy and cell therapy are being actively pursued.
Europe Europe is the second-largest market, with countries like Germany, France, and the UK leading in the adoption of leukapheresis for therapeutic treatments and stem cell collections. The region’s strong healthcare infrastructure and growing emphasis on cancer research contribute to its growth.
Asia-Pacific The Asia-Pacific region is expected to experience the highest growth rate due to improving healthcare systems, rising cancer incidences, and increasing investments in advanced medical technologies. Countries such as China and India are emerging as key players in the leukapheresis market.
Latin America and Middle East & Africa These regions are witnessing gradual growth in the leukapheresis market, driven by improving healthcare accessibility and the rising number of blood disorder cases, particularly in major cities and healthcare hubs.

Key Challenges

High Treatment Costs Leukapheresis treatment can be expensive, especially for cancer patients undergoing stem cell transplants or immunotherapy. The cost of apheresis devices, consumables, and the complexity of the procedures can limit access to the treatment in low-income regions.
Limited Availability of Skilled Professionals Leukapheresis is a specialized procedure that requires trained healthcare professionals and expertise in managing complex patient conditions. A shortage of skilled practitioners in certain regions can hinder the widespread adoption of this therapy.
Regulatory Challenges While leukapheresis technologies are generally well-regulated in developed markets, navigating the regulatory landscapes in emerging regions can pose challenges for market expansion, particularly with respect to the approval and distribution of new devices and therapies.

Future Outlook

The leukapheresis market is set for significant growth, driven by increasing incidences of cancer, advancements in immunotherapies like CAR-T cell therapy, and the rising demand for stem cell collection and transplantation. Technological innovations in leukapheresis devices, along with the expanding healthcare infrastructure in emerging markets, are expected to contribute to the market’s continued expansion.

The focus on personalized medicine, cell therapy, and immuno-oncology will likely propel the demand for leukapheresis technologies, providing new opportunities for manufacturers and healthcare providers. Additionally, as awareness of the benefits of leukapheresis grows, more healthcare facilities are expected to integrate these treatments into their offerings.

Leading Market Players

Prominent players in the leukapheresis market include:

Terumo BCT
Fresenius Kabi AG
Haemonetics Corporation
Asahi Kasei Medical Co., Ltd.
Medtronic
Memphasys Limited

Conclusion

The leukapheresis market is poised for continued growth, driven by advancements in treatment technologies and an increasing focus on cancer therapies and stem cell research. With rising demand for these treatments, the market offers significant opportunities for medical device manufacturers, healthcare providers, and researchers. However, addressing challenges such as high costs and skill shortages will be critical to ensuring the wider adoption and success of leukapheresis procedures.

For more detailed insights into the leukapheresis market, including data on regional growth and technological advancements, feel free to reach out for customized reports and analysis.

✈👉Enquiry for buying: 🚀https://www.zionmarketresearch.com/inquiry/leukapheresis-market